Learning the interaction rules of antibody-antigen binding
This project aims to enhance antibody-antigen binding prediction by generating large-scale sequence and structural data through high-throughput screening and machine learning techniques.
Projectdetails
Introduction
Antibody-antigen binding is the basis of two fundamental biotherapeutic pillars: monoclonal antibodies (1) and vaccines (2). To accelerate therapeutics discovery, we need to perform antibody (Ab) and antigen (Ag) design in silico. Specifically, we need to address a fundamental immuno-biotechnological challenge: understanding the interaction rules that predict Ab-Ag binding. Solving this challenge demands the convergence of biotechnology, computational structural biology, and machine learning (ML). My lab is one of the few worldwide to have this transdisciplinary expertise.
Research Problem
Currently, the predictive performance of Ab-Ag binding is poor, and an understanding of the underlying rules of Ab-Ag binding is mostly absent. We previously showed that both unprecedentedly large datasets (>10^5 Ab-Ag sequence pairs) and extensive structural information on the Ab-Ag binding interface (paratope, epitope) are needed to increase prediction accuracy and recover binding rules.
Targeted Breakthrough
To address the lack of large-scale Ab-Ag sequence and structural data, we will develop a method for high-throughput screening of:
-
10^3 Ab paratope-mutated variants
-
10^3 Ag epitope-mutated variants
This will generate sequence data of Ab-Ag binding pairs at an unprecedented scale (>10^6 sequence Ab-Ag pairs). Structural information of the entirety of the sequence-based Ab-Ag binding data will be generated by building and innovating on recent breakthroughs in computational structural biology.
To derive Ab-Ag interaction rules from the generated data, we will develop ML techniques for Ab-Ag binding prediction and rule recovery. We will demonstrate experimentally that we have begun to understand Ab-Ag interaction rules.
Impact
The proposed research generates the exact data necessary to recover the rules of Ab-Ag binding and provides a first groundbreaking insight into those rules, moving us closer to in silico on-demand antibody and vaccine design.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.000.000 |
Totale projectbegroting | € 2.000.000 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITETET I OSLOpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MANUNKIND: Determinants and Dynamics of Collaborative ExploitationThis project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery. | ERC STG | € 1.497.749 | 2022 | Details |
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressureThe UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance. | ERC STG | € 1.498.280 | 2022 | Details |
Uncovering the mechanisms of action of an antiviral bacteriumThis project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function. | ERC STG | € 1.500.000 | 2023 | Details |
The Ethics of Loneliness and SociabilityThis project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field. | ERC STG | € 1.025.860 | 2023 | Details |
MANUNKIND: Determinants and Dynamics of Collaborative Exploitation
This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure
The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.
Uncovering the mechanisms of action of an antiviral bacterium
This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.
The Ethics of Loneliness and Sociability
This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Accelerated Discovery Nanobody PlatformThe ALADDIN project aims to revolutionize therapeutic antibody discovery for cancer by integrating nanobody technology, AI tools, and innovative models to enhance efficiency and reduce reliance on animal testing. | EIC Pathfinder | € 3.315.441 | 2024 | Details |
REVisiting Antibody structures and repertoires through advances in Mass spectrometry and ProteomicsREVAMP aims to develop innovative mass spectrometry techniques to comprehensively analyze the structural and functional diversity of human antibody repertoires, enhancing our understanding of immune responses. | ERC ADG | € 2.500.000 | 2025 | Details |
Computational design of synthetic antibody repertoires for accelerated therapeutic discoveryCADABRE aims to design and optimize diverse human antibody repertoires with enhanced stability and developability for therapeutic discovery using advanced protein design and AI-driven screening methods. | ERC ADG | € 2.741.000 | 2024 | Details |
Dissecting the Functional Role of Mucosal IgA Clonal and Glycoprofiles for Effective Humoral Mucosal ProtectionThis project aims to characterize mucosal IgA proteoforms to enhance vaccine and monoclonal antibody development for improved respiratory immunity against viral threats. | ERC STG | € 1.486.245 | 2025 | Details |
Accelerated Discovery Nanobody Platform
The ALADDIN project aims to revolutionize therapeutic antibody discovery for cancer by integrating nanobody technology, AI tools, and innovative models to enhance efficiency and reduce reliance on animal testing.
REVisiting Antibody structures and repertoires through advances in Mass spectrometry and Proteomics
REVAMP aims to develop innovative mass spectrometry techniques to comprehensively analyze the structural and functional diversity of human antibody repertoires, enhancing our understanding of immune responses.
Computational design of synthetic antibody repertoires for accelerated therapeutic discovery
CADABRE aims to design and optimize diverse human antibody repertoires with enhanced stability and developability for therapeutic discovery using advanced protein design and AI-driven screening methods.
Dissecting the Functional Role of Mucosal IgA Clonal and Glycoprofiles for Effective Humoral Mucosal Protection
This project aims to characterize mucosal IgA proteoforms to enhance vaccine and monoclonal antibody development for improved respiratory immunity against viral threats.